Multi-Drug Implications for COVID-19 Treatment, Opioid Safety, and Quality Measures

Posted On by

Join Quality Institute member Tabula Rasa Healthcare, for this free webinar. They will review pharmacokinetic and pharmacodynamic concerns with opioids, potential COVID-19 treatment options, and medication use in older adults. Through case examples, it will provide insight into how technology can be leveraged to reduce medication-related problems and improve patient outcomes. Attendees will learn: 

  • Recognize the risk associated with polypharmacy in the older adult
  • Describe how variations in individual pharmacokinetic and pharmacodynamic parameters may impact the risk for adverse events
  • Identify methods for minimizing the impact of given risk factors for adverse events in patients with polypharmacy.

Register Here